medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2005, Número 3

<< Anterior Siguiente >>

Rev Inst Nal Enf Resp Mex 2005; 18 (3)


La función plaquetaria más allá de la hemostasis: participación en las enfermedades respiratorias

Guzmán GAM, Maldonado NL, Mendoza AR, Hicks GJJ

Idioma: Español
Referencias bibliográficas: 40
Paginas: 240-246
Archivo PDF: 66.97 Kb.


RESUMEN

Actualmente se sabe que las plaquetas, además de almacenar diversos mediadores químicos, también tienen la capacidad de realizar síntesis de varios tipos de proteínas a partir de ARN preformados y de interaccionar con diversos tipos de partículas, con componentes de la matriz extracelular y con varios tipos celulares. Estas características posibilitan a las plaquetas intervenir activamente, no sólo en la hemostasis y trombosis, sino también en la inflamación, remodelación tisular y posiblemente en la defensa innata.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003;1:1897-1905.

  2. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol 2004;25:489-495.

  3. Lewis JC, Maldonado JE, Mann KG. Phagocytosis in human platelets: localization of acid phosphatase-positive phagosomes following latex uptake. Blood 1976;47:833-840.

  4. Zucker-Franklin. Endocytosis by human platelets: metabolic and freeze-fracture studies. J Cell Biol 1981;91:706-715.

  5. Clawson CC, Rao GHR, White JG. Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol 1975;81:411-420.

  6. Joseph M, Auriault C, Capron A, Vorng H, Viens P. A new function of platelets: IgE-dependent killing of schistosomes. Nature 1984;302:810-812.

  7. Mesenguer J, Esteban MA, Rodríguez A. Are thrombocytes and platelets true phagocytes? Microsc Res Tech 2002;57:491-497.

  8. Gear AR, Camerini D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 2003;10:335-350.

  9. Booyse FM, Rafelson ME. Stable messenger RNA in the synthesis of contractile proteins in human platelets. Biochim Biophys Acta 1967;145:188-190.

  10. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003;101:2285-2293.

  11. Kieffer N, Guichard J, Farcet JP, Vainchenker W, Breton-Gorius J. Biosynthesis of major platelets proteins in human blood platelets. Eur J Biochem 1987; 164:189-195.

  12. Lindemann S, Tolley ND, Dixon DA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001; 154:485-490.

  13. Rosenwald IB, Pechet L, Han A, et al. Expression and translation initiation factors e1F-4E and e1F-2alpha and a potential physiologic role of continuous protein synthesis in human platelets. Thromb Haemost 2001; 85:142-151.

  14. Brown EJ, Schreiber SL. A signaling pathway to translational control. Cell 1996; 86: 517-520.

  15. Lindemann S, Tolley ND, Eyre JR, Kraiss LW, Mahoney TM, Weyrich AS. Integrins regulates the intracellular distribution of eukaryotic initiation factor 4E in platelets: a checkpoint for translational control. J Biol Chem 2001;276:33947-33951.

  16. Paul A, Wilson S, Belham CM, et al. Stress-activated protein kinases: activation, regulation and function. Cell Signal 1997;9:403-410.

  17. Kramer RM, Roberts EF, Strifler BA, Johnstone EM. Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem 1995;270:27395-27398.

  18. Brown SB, Clarke MC, Magowan L, Sanderson H, Savill J. Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis: a caspase-independent cell clearance program. J Biol Chem 2000;275:5987-5996.

  19. Czapiga M, Gao JL, Kirk A, Lekstrom-Himes J. Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. Exp Hematol 2005;33:73-84.

  20. Martin JF, Slater DN, Trowbridge EA. Abnormal intrapulmonary platelet production: a possible cause of vascular and lung disease. Lancet 1983;1:793-796.

  21. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:806-817.

  22. Metzger WJ, Sjoerdsma K, Richerson HB, et al. Platelets in bronchoalveolar lavage from asthmatic patients and allergic rabbits with allergen-induced late phase responses. Agents Actions Suppl 1987; 21:151-159.

  23. Gresele P, Dottorini M, Selli ML, et al. Altered platelet function associated with the bronchial hyper-responsiveness accompanying nocturnal asthma. J Allergy Clin Immunol 1993;91:894-902.

  24. Coyle AJ, Page CP, Atkinson L, Flanagan R, Metzger WJ. The requirement for platelets in allergen-induced late asthmatic airway obstruction. Eosinophil infiltration and heightened airway responsiveness in allergic rabbits. Am Rev Respir Dis 1990;142:587-593.

  25. Pitchford SC, Yano H, Lever R, et al. Platelets are essential for leukocyte recruitment in allergic inflammation. J Allergy Clin Immunol 2003;112:109-118.

  26. Ulfman LH, Joosten DP, van Aalst CW, et al. Platelets promote eosinophil adhesion of patients with asthma to endothelium under flow conditions. Am J Respir Cell Mol Biol 2003;28:512-519.

  27. Morley J, Sanjar S, Page CP. The platelet in asthma. Lancet 1984;1:1142-1144.

  28. Clark RA, Folkvord JM, Hart CE, Murray MJ, McPherson JM. Platelet isoforms of platelet-derived growth factor stimulate fibroblasts to contract collagen matrices. J Clin Invest 1989;84:1036-1040.

  29. Zhu Y, Skold CM, Liu X, et al. Fibroblast and monocyte macrophages contract and degrade three-dimensional collagen gels in extended co-culture. Respir Res 2001;2:295-299.

  30. Zagai U, Fredriksson K, Rennard SI, Lundahl J, Skold M. Platelets stimulate fibroblast-mediated contraction of collagen gels. Respir Res 2003;4:13.

  31. Pitchford SC, Riffo-Vasquez Y, Sousa A, et al. Platelets are necessary for airwall remodeling in a murine model of chronic allergic inflammation. Blood 2004; 103:639-647.

  32. Wedzicha JA, Syndercombe-Court D, Tan KC. Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxemia. Thorax 1991; 46:504-507.

  33. Ferroni P, Basili S, Pulcinelli FM, et al. In vivo thrombin generation and platelet hyperactivity in patients with chronic obstructive pulmonary disease. Platelets 1994;5:276-277.

  34. Basili S, Ferroni P, Pulcinelli FM, et al. Potential usefulness of antiplatelet agents in patients with chronic obstructive pulmonary disease. Thromb Res 1996; 4:279-284.

  35. Davi G, Basili S, Vieri M, et al. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. Am J Crit Care Med 1997;156:1794-1799.

  36. Ferroni P, Basili S, Martini F, et al. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J Investing Med 2000;48:21-27.

  37. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelet regulates aggregation. Proc Natl Acad Sci USA 1990;87:5193-5197.

  38. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Michelson AD. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997;100:350-356.

  39. Ichiki K, Ikeda H, Haramaki N, Ueno T, Imaizumi T. Long-term smoking impairs platelet-derived nitric oxide release. Circulation 1996;94:3109-3114.

  40. Takajo Y, Ikeda H, Haramaki N, Murohara T, Imaizumi T. Augmented oxidative stress of platelets in chronic smokers. Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet agreegability. J Am Coll Cardiol 2001;38:1320-1327.




2020     |     www.medigraphic.com